Changing Paradigms in Hereditary Angioedema: A Focus on Timely Diagnosis and New...( VOORHEES N.J. July 9 /- Hereditary an...),Health

VOORHEES, N.J., July 9 /PRNewswire/ -- Hereditary angioedema (HAE) is an autosomal dominant disease affecting approximately 10,000 people in the United States. HAE causes recurrent attacks of intense localized edema involving the skin, airway, and visceral organs. While chronic therapy with attenuated androgens or plasmin inhibitors has been the mainstay of HAE therapy, many new therapies for prophylaxis and acute treatment are on the horizon. It is important for physicians to understand the signs and symptoms of patients who present with HAE and to be familiar with the conventional and emerging therapies available to treat them.

To address the need for current education on HAE, Robert Michael Educational Institute LLC (RMEI) and Postgraduate Institute for Medicine (PIM) are jointly sponsoring a complimentary continuing medical education self-study audio activity titled Changing Paradigms in Hereditary Angioedema: A Focus on Timely Diagnosis and New Therapies. This activity is supported by an educational grant from ViroPharma Incorporated.

Faculty for this continuing medical education activity include the following experts in allergy and immunology: Allen P. Kaplan, MD, from Medical University of South Carolina in Charleston, South Carolina; Bruce L. Zuraw, MD, from the University of California School of Medicine in San Diego, California; and Paula J. Busse, MD, from the Mount Sinai School of Medicine in New York.

Healthcare professionals can visit www.RMEI.com/HAECD to download the audio MP3 and activity workbook.

"Quality continuing medical education is vital to developing and increasing knowledge and skills and enhancing patient care," says Robert Michael Educational Institute LLC President and CEO, Robert M. Colleluori.

RMEI is a medical education company that specializes in indepen
'/>"/>